Investigative Ophthalmology & Visual Science, Vol 37, 1348-1359, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys

KS Crawford, SJ Gange, BT Gabelt, W Heideman, JC Robinson, WC Hubbard and PL Kaufman
Department of Ophthalmology, University of Wisconsin, Madison 53792- 3220, USA.

PURPOSE. To investigate the effect of indomethacin inhibition of prostanoid production on the epinephrine-stimulated increase in outflow facility and cyclic adenosine monophosphate (cAMP) production in the anterior segment of the monkey eye. METHODS. Topical indomethacin was given 1 hour before the intracameral administration of epinephrine to living cynomolgus monkeys. Outflow facility was measured for 45 to 60 minutes, beginning 3 hours after epinephrine administration, by two- level constant pressure perfusion of the anterior chamber. Cyclic adenosine monophosphate formation was measured in cell membranes isolated from rhesus monkey ciliary muscle, ciliary processes, trabecular meshwork, and iris in the presence of forskolin, indomethacin, epinephrine, or indomethacin and epinephrine combined. RESULTS. Three hours after the intracameral administration of 5.5 micrograms epinephrine, facility increased by approximately 40%, a putatively maximal response, at which time the intracameral epinephrine concentration was approximately 15 microM. Pretreatment with topical indomethacin produced a dose-dependent inhibition of epinephrine's facility-increasing effect; the maximum inhibition of 50% to 70% occurred at an indomethacin dose of 50 to 125 micrograms. Doubling the indomethacin dose (250 micrograms) produced no further inhibition, whereas a fivefold larger epinephrine dose (27.5 micrograms) did not overcome the inhibition. Forskolin and epinephrine both stimulated cAMP production in vitro, whereas [indomethacin] > or = 10(-4) M partially inhibited both basal and epinephrine-stimulated cAMP production in all four tissues. CONCLUSIONS. Approximately half of the epinephrine- induced facility increase is inhibited by indomethacin, but it is unclear whether the indomethacin-inhibitable fraction is mediated by epinephrine-stimulated prostanoid production or release.

This article has been cited by other articles:

				Z. Wan, D. F. Woodward, C. L. Cornell, H. G. Fliri, J. L. Martos, S. N. Pettit, J. W. Wang, A. B. Kharlamb, L. A. Wheeler, M. E. Garst, et al. Bimatoprost, Prostamide Activity, and Conventional Drainage Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4107 - 4115. [Abstract] [Full Text] [PDF]

				P. Gonzalez, D. L. Epstein, and T. Borrás Genes Upregulated in the Human Trabecular Meshwork in Response to Elevated Intraocular Pressure Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 352 - 361. [Abstract] [Full Text]

				C. E. Crosson and M. Petrovich Contributions of Adenosine Receptor Activation to the Ocular Actions of Epinephrine Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2054 - 2061. [Abstract] [Full Text] [PDF]

				M. A. Croft, R. F. Wang, S. M. Podos, A. H. Neufeld, and P. L. Kaufman Effect of Ticrynafen on Aqueous Humor Dynamics in Monkeys Arch Ophthalmol, November 1, 1998; 116(11): 1481 - 1488. [Abstract] [Full Text] [PDF]